nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—nerve—type 2 diabetes mellitus	0.00888	0.241	CbGeAlD
Acamprosate—GRIN2B—nerve—type 2 diabetes mellitus	0.00702	0.19	CbGeAlD
Acamprosate—GRIN2A—nerve—type 2 diabetes mellitus	0.00613	0.166	CbGeAlD
Acamprosate—SLC36A1—nephron tubule—type 2 diabetes mellitus	0.00238	0.0644	CbGeAlD
Acamprosate—SLC36A1—kidney—type 2 diabetes mellitus	0.00209	0.0566	CbGeAlD
Acamprosate—SLC36A1—pancreas—type 2 diabetes mellitus	0.00208	0.0562	CbGeAlD
Acamprosate—SLC36A1—cortex of kidney—type 2 diabetes mellitus	0.00204	0.0551	CbGeAlD
Acamprosate—SLC36A1—adipose tissue—type 2 diabetes mellitus	0.00188	0.051	CbGeAlD
Acamprosate—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.00144	0.039	CbGeAlD
Acamprosate—SLC36A1—liver—type 2 diabetes mellitus	0.00132	0.0358	CbGeAlD
Acamprosate—GABRB3—pancreas—type 2 diabetes mellitus	0.00101	0.0274	CbGeAlD
Acamprosate—GABRB3—liver—type 2 diabetes mellitus	0.000643	0.0174	CbGeAlD
Acamprosate—Angioedema—Losartan—type 2 diabetes mellitus	0.00029	0.000437	CcSEcCtD
Acamprosate—Infection—Metformin—type 2 diabetes mellitus	0.00029	0.000436	CcSEcCtD
Acamprosate—Insomnia—Valsartan—type 2 diabetes mellitus	0.00029	0.000436	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000288	0.000434	CcSEcCtD
Acamprosate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000287	0.000433	CcSEcCtD
Acamprosate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000287	0.000432	CcSEcCtD
Acamprosate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000287	0.000432	CcSEcCtD
Acamprosate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000287	0.000432	CcSEcCtD
Acamprosate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000287	0.000432	CcSEcCtD
Acamprosate—Shock—Metformin—type 2 diabetes mellitus	0.000287	0.000432	CcSEcCtD
Acamprosate—Insomnia—Orlistat—type 2 diabetes mellitus	0.000286	0.000431	CcSEcCtD
Acamprosate—Malaise—Losartan—type 2 diabetes mellitus	0.000286	0.000431	CcSEcCtD
Acamprosate—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000286	0.000431	CcSEcCtD
Acamprosate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000286	0.000431	CcSEcCtD
Acamprosate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000285	0.00043	CcSEcCtD
Acamprosate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000285	0.00043	CcSEcCtD
Acamprosate—Vertigo—Losartan—type 2 diabetes mellitus	0.000285	0.000429	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000285	0.000429	CcSEcCtD
Acamprosate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000285	0.000429	CcSEcCtD
Acamprosate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000285	0.000429	CcSEcCtD
Acamprosate—Syncope—Losartan—type 2 diabetes mellitus	0.000284	0.000429	CcSEcCtD
Acamprosate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000284	0.000428	CcSEcCtD
Acamprosate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000284	0.000428	CcSEcCtD
Acamprosate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000284	0.000427	CcSEcCtD
Acamprosate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000283	0.000427	CcSEcCtD
Acamprosate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000282	0.000425	CcSEcCtD
Acamprosate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000282	0.000425	CcSEcCtD
Acamprosate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000282	0.000424	CcSEcCtD
Acamprosate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000281	0.000423	CcSEcCtD
Acamprosate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000281	0.000423	CcSEcCtD
Acamprosate—Palpitations—Losartan—type 2 diabetes mellitus	0.00028	0.000422	CcSEcCtD
Acamprosate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000279	0.000421	CcSEcCtD
Acamprosate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000279	0.00042	CcSEcCtD
Acamprosate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00042	CcSEcCtD
Acamprosate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000278	0.000419	CcSEcCtD
Acamprosate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000278	0.000419	CcSEcCtD
Acamprosate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000278	0.000419	CcSEcCtD
Acamprosate—Anorexia—Metformin—type 2 diabetes mellitus	0.000278	0.000419	CcSEcCtD
Acamprosate—Cough—Losartan—type 2 diabetes mellitus	0.000277	0.000417	CcSEcCtD
Acamprosate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000277	0.000417	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000276	0.000416	CcSEcCtD
Acamprosate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000276	0.000416	CcSEcCtD
Acamprosate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000275	0.000415	CcSEcCtD
Acamprosate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000275	0.000415	CcSEcCtD
Acamprosate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000275	0.000414	CcSEcCtD
Acamprosate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000275	0.000414	CcSEcCtD
Acamprosate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000275	0.000414	CcSEcCtD
Acamprosate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000274	0.000412	CcSEcCtD
Acamprosate—Constipation—Valsartan—type 2 diabetes mellitus	0.000274	0.000412	CcSEcCtD
Acamprosate—Infection—Irbesartan—type 2 diabetes mellitus	0.000273	0.000412	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000273	0.000411	CcSEcCtD
Acamprosate—Hypotension—Metformin—type 2 diabetes mellitus	0.000272	0.00041	CcSEcCtD
Acamprosate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000272	0.00041	CcSEcCtD
Acamprosate—Shock—Irbesartan—type 2 diabetes mellitus	0.000271	0.000408	CcSEcCtD
Acamprosate—Pain—Orlistat—type 2 diabetes mellitus	0.000271	0.000407	CcSEcCtD
Acamprosate—Arthralgia—Losartan—type 2 diabetes mellitus	0.00027	0.000407	CcSEcCtD
Acamprosate—Chest pain—Losartan—type 2 diabetes mellitus	0.00027	0.000407	CcSEcCtD
Acamprosate—Myalgia—Losartan—type 2 diabetes mellitus	0.00027	0.000407	CcSEcCtD
Acamprosate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00027	0.000407	CcSEcCtD
Acamprosate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000269	0.000406	CcSEcCtD
Acamprosate—Anxiety—Losartan—type 2 diabetes mellitus	0.000269	0.000405	CcSEcCtD
Acamprosate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000269	0.000404	CcSEcCtD
Acamprosate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000268	0.000403	CcSEcCtD
Acamprosate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000267	0.000403	CcSEcCtD
Acamprosate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000267	0.000403	CcSEcCtD
Acamprosate—Tension—Ramipril—type 2 diabetes mellitus	0.000267	0.000402	CcSEcCtD
Acamprosate—Discomfort—Losartan—type 2 diabetes mellitus	0.000267	0.000402	CcSEcCtD
Acamprosate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000266	0.000401	CcSEcCtD
Acamprosate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000266	0.000401	CcSEcCtD
Acamprosate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000266	0.000401	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000266	0.0004	CcSEcCtD
Acamprosate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000266	0.0004	CcSEcCtD
Acamprosate—Nervousness—Ramipril—type 2 diabetes mellitus	0.000264	0.000398	CcSEcCtD
Acamprosate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000264	0.000398	CcSEcCtD
Acamprosate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000262	0.000395	CcSEcCtD
Acamprosate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000262	0.000394	CcSEcCtD
Acamprosate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000262	0.000394	CcSEcCtD
Acamprosate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000262	0.000394	CcSEcCtD
Acamprosate—Confusional state—Losartan—type 2 diabetes mellitus	0.000261	0.000393	CcSEcCtD
Acamprosate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000261	0.000393	CcSEcCtD
Acamprosate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00026	0.000391	CcSEcCtD
Acamprosate—Somnolence—Metformin—type 2 diabetes mellitus	0.000259	0.00039	CcSEcCtD
Acamprosate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000259	0.00039	CcSEcCtD
Acamprosate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000259	0.00039	CcSEcCtD
Acamprosate—Infection—Losartan—type 2 diabetes mellitus	0.000257	0.000387	CcSEcCtD
Acamprosate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000257	0.000387	CcSEcCtD
Acamprosate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000257	0.000387	CcSEcCtD
Acamprosate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000257	0.000387	CcSEcCtD
Acamprosate—Tremor—Ramipril—type 2 diabetes mellitus	0.000255	0.000384	CcSEcCtD
Acamprosate—Shock—Losartan—type 2 diabetes mellitus	0.000255	0.000384	CcSEcCtD
Acamprosate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000254	0.000383	CcSEcCtD
Acamprosate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000254	0.000382	CcSEcCtD
Acamprosate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000253	0.000382	CcSEcCtD
Acamprosate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000253	0.000381	CcSEcCtD
Acamprosate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000253	0.000381	CcSEcCtD
Acamprosate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000252	0.00038	CcSEcCtD
Acamprosate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00038	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000252	0.000379	CcSEcCtD
Acamprosate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000251	0.000379	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000251	0.000378	CcSEcCtD
Acamprosate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00025	0.000377	CcSEcCtD
Acamprosate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00025	0.000377	CcSEcCtD
Acamprosate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00025	0.000377	CcSEcCtD
Acamprosate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00025	0.000377	CcSEcCtD
Acamprosate—Agitation—Ramipril—type 2 diabetes mellitus	0.00025	0.000377	CcSEcCtD
Acamprosate—Constipation—Metformin—type 2 diabetes mellitus	0.000249	0.000376	CcSEcCtD
Acamprosate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000249	0.000374	CcSEcCtD
Acamprosate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000247	0.000372	CcSEcCtD
Acamprosate—Anorexia—Losartan—type 2 diabetes mellitus	0.000247	0.000372	CcSEcCtD
Acamprosate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000247	0.000372	CcSEcCtD
Acamprosate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000247	0.000371	CcSEcCtD
Acamprosate—Malaise—Ramipril—type 2 diabetes mellitus	0.000245	0.000369	CcSEcCtD
Acamprosate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000245	0.000369	CcSEcCtD
Acamprosate—Rash—Glyburide—type 2 diabetes mellitus	0.000245	0.000369	CcSEcCtD
Acamprosate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000245	0.000368	CcSEcCtD
Acamprosate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000244	0.000368	CcSEcCtD
Acamprosate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000244	0.000368	CcSEcCtD
Acamprosate—Syncope—Ramipril—type 2 diabetes mellitus	0.000244	0.000367	CcSEcCtD
Acamprosate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000243	0.000367	CcSEcCtD
Acamprosate—Headache—Glyburide—type 2 diabetes mellitus	0.000243	0.000366	CcSEcCtD
Acamprosate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000242	0.000365	CcSEcCtD
Acamprosate—Hypotension—Losartan—type 2 diabetes mellitus	0.000242	0.000364	CcSEcCtD
Acamprosate—Palpitations—Ramipril—type 2 diabetes mellitus	0.00024	0.000362	CcSEcCtD
Acamprosate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00024	0.000362	CcSEcCtD
Acamprosate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000239	0.00036	CcSEcCtD
Acamprosate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000239	0.00036	CcSEcCtD
Acamprosate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000238	0.000359	CcSEcCtD
Acamprosate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000238	0.000359	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000238	0.000358	CcSEcCtD
Acamprosate—Cough—Ramipril—type 2 diabetes mellitus	0.000237	0.000358	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000236	0.000355	CcSEcCtD
Acamprosate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000236	0.000355	CcSEcCtD
Acamprosate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000236	0.000355	CcSEcCtD
Acamprosate—Pain—Irbesartan—type 2 diabetes mellitus	0.000235	0.000354	CcSEcCtD
Acamprosate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000235	0.000354	CcSEcCtD
Acamprosate—Insomnia—Losartan—type 2 diabetes mellitus	0.000234	0.000353	CcSEcCtD
Acamprosate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000233	0.000351	CcSEcCtD
Acamprosate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000232	0.00035	CcSEcCtD
Acamprosate—Urticaria—Metformin—type 2 diabetes mellitus	0.000232	0.000349	CcSEcCtD
Acamprosate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000232	0.000349	CcSEcCtD
Acamprosate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000232	0.000349	CcSEcCtD
Acamprosate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000232	0.000349	CcSEcCtD
Acamprosate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000231	0.000348	CcSEcCtD
Acamprosate—Anxiety—Ramipril—type 2 diabetes mellitus	0.000231	0.000348	CcSEcCtD
Acamprosate—Nausea—Glyburide—type 2 diabetes mellitus	0.00023	0.000347	CcSEcCtD
Acamprosate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00023	0.000347	CcSEcCtD
Acamprosate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00023	0.000347	CcSEcCtD
Acamprosate—Somnolence—Losartan—type 2 diabetes mellitus	0.00023	0.000347	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00023	0.000346	CcSEcCtD
Acamprosate—Asthenia—Valsartan—type 2 diabetes mellitus	0.00023	0.000346	CcSEcCtD
Acamprosate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000229	0.000345	CcSEcCtD
Acamprosate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000228	0.000343	CcSEcCtD
Acamprosate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000227	0.000342	CcSEcCtD
Acamprosate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000227	0.000341	CcSEcCtD
Acamprosate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000226	0.000341	CcSEcCtD
Acamprosate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000226	0.000341	CcSEcCtD
Acamprosate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000225	0.000339	CcSEcCtD
Acamprosate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000225	0.000339	CcSEcCtD
Acamprosate—Confusional state—Ramipril—type 2 diabetes mellitus	0.000224	0.000337	CcSEcCtD
Acamprosate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000224	0.000337	CcSEcCtD
Acamprosate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000222	0.000334	CcSEcCtD
Acamprosate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000222	0.000334	CcSEcCtD
Acamprosate—Pain—Losartan—type 2 diabetes mellitus	0.000221	0.000333	CcSEcCtD
Acamprosate—Constipation—Losartan—type 2 diabetes mellitus	0.000221	0.000333	CcSEcCtD
Acamprosate—Rash—Gliclazide—type 2 diabetes mellitus	0.00022	0.000331	CcSEcCtD
Acamprosate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000219	0.000331	CcSEcCtD
Acamprosate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000219	0.00033	CcSEcCtD
Acamprosate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000219	0.000329	CcSEcCtD
Acamprosate—Shock—Ramipril—type 2 diabetes mellitus	0.000218	0.000329	CcSEcCtD
Acamprosate—Headache—Gliclazide—type 2 diabetes mellitus	0.000218	0.000329	CcSEcCtD
Acamprosate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000217	0.000328	CcSEcCtD
Acamprosate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000217	0.000328	CcSEcCtD
Acamprosate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000217	0.000327	CcSEcCtD
Acamprosate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000217	0.000326	CcSEcCtD
Acamprosate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000216	0.000326	CcSEcCtD
Acamprosate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000216	0.000325	CcSEcCtD
Acamprosate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000215	0.000323	CcSEcCtD
Acamprosate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000213	0.000321	CcSEcCtD
Acamprosate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000212	0.000319	CcSEcCtD
Acamprosate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000212	0.000319	CcSEcCtD
Acamprosate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000212	0.000319	CcSEcCtD
Acamprosate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000209	0.000315	CcSEcCtD
Acamprosate—Asthenia—Metformin—type 2 diabetes mellitus	0.000209	0.000315	CcSEcCtD
Acamprosate—Hypotension—Ramipril—type 2 diabetes mellitus	0.000207	0.000312	CcSEcCtD
Acamprosate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000207	0.000312	CcSEcCtD
Acamprosate—Pruritus—Metformin—type 2 diabetes mellitus	0.000206	0.000311	CcSEcCtD
Acamprosate—Urticaria—Losartan—type 2 diabetes mellitus	0.000206	0.00031	CcSEcCtD
Acamprosate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000205	0.000308	CcSEcCtD
Acamprosate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000205	0.000308	CcSEcCtD
Acamprosate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000204	0.000307	CcSEcCtD
Acamprosate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000203	0.000305	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000202	0.000305	CcSEcCtD
Acamprosate—Rash—Valsartan—type 2 diabetes mellitus	0.000202	0.000304	CcSEcCtD
Acamprosate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000202	0.000304	CcSEcCtD
Acamprosate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000201	0.000303	CcSEcCtD
Acamprosate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000201	0.000302	CcSEcCtD
Acamprosate—Headache—Valsartan—type 2 diabetes mellitus	0.000201	0.000302	CcSEcCtD
Acamprosate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000199	0.0003	CcSEcCtD
Acamprosate—Rash—Orlistat—type 2 diabetes mellitus	0.000199	0.0003	CcSEcCtD
Acamprosate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000199	0.0003	CcSEcCtD
Acamprosate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000199	0.0003	CcSEcCtD
Acamprosate—Headache—Orlistat—type 2 diabetes mellitus	0.000198	0.000298	CcSEcCtD
Acamprosate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000198	0.000298	CcSEcCtD
Acamprosate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000197	0.000297	CcSEcCtD
Acamprosate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000197	0.000297	CcSEcCtD
Acamprosate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000195	0.000294	CcSEcCtD
Acamprosate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000195	0.000293	CcSEcCtD
Acamprosate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000193	0.000291	CcSEcCtD
Acamprosate—Dizziness—Metformin—type 2 diabetes mellitus	0.000193	0.00029	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000192	0.000289	CcSEcCtD
Acamprosate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000191	0.000287	CcSEcCtD
Acamprosate—Nausea—Valsartan—type 2 diabetes mellitus	0.00019	0.000286	CcSEcCtD
Acamprosate—Constipation—Ramipril—type 2 diabetes mellitus	0.00019	0.000286	CcSEcCtD
Acamprosate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000188	0.000284	CcSEcCtD
Acamprosate—Nausea—Orlistat—type 2 diabetes mellitus	0.000188	0.000283	CcSEcCtD
Acamprosate—Asthenia—Losartan—type 2 diabetes mellitus	0.000186	0.00028	CcSEcCtD
Acamprosate—Vomiting—Metformin—type 2 diabetes mellitus	0.000185	0.000279	CcSEcCtD
Acamprosate—Rash—Metformin—type 2 diabetes mellitus	0.000184	0.000277	CcSEcCtD
Acamprosate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000184	0.000277	CcSEcCtD
Acamprosate—Pruritus—Losartan—type 2 diabetes mellitus	0.000183	0.000276	CcSEcCtD
Acamprosate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000183	0.000276	CcSEcCtD
Acamprosate—Headache—Metformin—type 2 diabetes mellitus	0.000183	0.000275	CcSEcCtD
Acamprosate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000182	0.000274	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000182	0.000273	CcSEcCtD
Acamprosate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000177	0.000267	CcSEcCtD
Acamprosate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000176	0.000266	CcSEcCtD
Acamprosate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000175	0.000264	CcSEcCtD
Acamprosate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000175	0.000264	CcSEcCtD
Acamprosate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000175	0.000263	CcSEcCtD
Acamprosate—Rash—Irbesartan—type 2 diabetes mellitus	0.000173	0.000261	CcSEcCtD
Acamprosate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000173	0.000261	CcSEcCtD
Acamprosate—Nausea—Metformin—type 2 diabetes mellitus	0.000173	0.000261	CcSEcCtD
Acamprosate—Headache—Irbesartan—type 2 diabetes mellitus	0.000172	0.00026	CcSEcCtD
Acamprosate—Dizziness—Losartan—type 2 diabetes mellitus	0.000171	0.000258	CcSEcCtD
Acamprosate—Vomiting—Losartan—type 2 diabetes mellitus	0.000165	0.000248	CcSEcCtD
Acamprosate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000164	0.000246	CcSEcCtD
Acamprosate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000163	0.000246	CcSEcCtD
Acamprosate—Rash—Losartan—type 2 diabetes mellitus	0.000163	0.000246	CcSEcCtD
Acamprosate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000163	0.000246	CcSEcCtD
Acamprosate—Headache—Losartan—type 2 diabetes mellitus	0.000162	0.000244	CcSEcCtD
Acamprosate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000159	0.00024	CcSEcCtD
Acamprosate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000157	0.000237	CcSEcCtD
Acamprosate—Nausea—Losartan—type 2 diabetes mellitus	0.000154	0.000232	CcSEcCtD
Acamprosate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000152	0.000229	CcSEcCtD
Acamprosate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000147	0.000221	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—IRS1—type 2 diabetes mellitus	0.000145	0.000485	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000144	0.000483	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000144	0.000482	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000144	0.000481	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000144	0.00048	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000143	0.000479	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	0.000143	0.000479	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	0.000143	0.000478	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CALM1—type 2 diabetes mellitus	0.000142	0.000475	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000142	0.000475	CbGpPWpGaD
Acamprosate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000141	0.000213	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000141	0.00047	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	0.000141	0.00047	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.00014	0.000469	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.00014	0.000469	CbGpPWpGaD
Acamprosate—Rash—Ramipril—type 2 diabetes mellitus	0.00014	0.000211	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.00014	0.000468	CbGpPWpGaD
Acamprosate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00014	0.000211	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.00014	0.000467	CbGpPWpGaD
Acamprosate—Headache—Ramipril—type 2 diabetes mellitus	0.000139	0.000209	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000139	0.000464	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000138	0.00046	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000138	0.00046	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000138	0.00046	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000138	0.00046	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000137	0.000459	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000137	0.000458	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000137	0.000457	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000137	0.000457	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000136	0.000456	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000136	0.000456	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000136	0.000455	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000136	0.000453	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000135	0.00045	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000134	0.000449	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—type 2 diabetes mellitus	0.000134	0.000447	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000134	0.000447	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000134	0.000447	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000133	0.000445	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000133	0.000443	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000133	0.000443	CbGpPWpGaD
Acamprosate—Nausea—Ramipril—type 2 diabetes mellitus	0.000132	0.000199	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000131	0.000439	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000131	0.000437	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.00013	0.000435	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.00013	0.000434	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000129	0.000431	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000127	0.000424	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000126	0.000422	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000126	0.000421	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000126	0.000421	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GNB3—type 2 diabetes mellitus	0.000126	0.00042	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000126	0.00042	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000125	0.000419	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000125	0.000417	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000125	0.000416	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000124	0.000415	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000123	0.000412	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000123	0.000412	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000123	0.00041	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000122	0.000408	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000122	0.000408	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000122	0.000408	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000122	0.000407	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000121	0.000403	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.00012	0.000402	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00012	0.000401	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000119	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000119	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000119	0.000399	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000118	0.000394	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000118	0.000394	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000118	0.000393	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000116	0.000387	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RELA—type 2 diabetes mellitus	0.000115	0.000384	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000115	0.000383	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000113	0.000377	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000112	0.000374	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000111	0.000371	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000111	0.00037	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00011	0.000368	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LPL—type 2 diabetes mellitus	0.00011	0.000367	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000109	0.000365	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000109	0.000365	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000109	0.000364	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000109	0.000364	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—type 2 diabetes mellitus	0.000108	0.000361	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000108	0.00036	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000108	0.00036	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000107	0.000359	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000107	0.000358	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000107	0.000358	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LPL—type 2 diabetes mellitus	0.000107	0.000358	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000106	0.000353	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000104	0.000349	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CD36—type 2 diabetes mellitus	0.000104	0.000349	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000104	0.000346	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—type 2 diabetes mellitus	0.000104	0.000346	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000102	0.000342	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CD36—type 2 diabetes mellitus	0.000102	0.00034	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000101	0.000339	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000101	0.000337	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000101	0.000337	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.0001	0.000336	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.0001	0.000335	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	9.9e-05	0.000331	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	9.9e-05	0.000331	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	9.84e-05	0.000329	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	9.78e-05	0.000327	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	9.72e-05	0.000325	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—type 2 diabetes mellitus	9.7e-05	0.000324	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	9.68e-05	0.000323	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	9.66e-05	0.000323	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CALM1—type 2 diabetes mellitus	9.62e-05	0.000322	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ADCY5—type 2 diabetes mellitus	9.61e-05	0.000321	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	9.6e-05	0.000321	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	9.55e-05	0.000319	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.5e-05	0.000318	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARA—type 2 diabetes mellitus	9.45e-05	0.000316	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CALM1—type 2 diabetes mellitus	9.45e-05	0.000316	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.41e-05	0.000315	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—type 2 diabetes mellitus	9.29e-05	0.00031	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.29e-05	0.00031	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.25e-05	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.21e-05	0.000308	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—type 2 diabetes mellitus	9.2e-05	0.000308	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.11e-05	0.000305	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	9.06e-05	0.000303	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCB—type 2 diabetes mellitus	9.04e-05	0.000302	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—type 2 diabetes mellitus	9.02e-05	0.000301	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOB—type 2 diabetes mellitus	8.98e-05	0.0003	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—type 2 diabetes mellitus	8.97e-05	0.0003	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.94e-05	0.000299	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCB—type 2 diabetes mellitus	8.88e-05	0.000297	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.83e-05	0.000295	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.65e-05	0.000289	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.65e-05	0.000289	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	8.64e-05	0.000289	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—type 2 diabetes mellitus	8.57e-05	0.000286	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	8.57e-05	0.000286	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	8.5e-05	0.000284	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.44e-05	0.000282	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	8.41e-05	0.000281	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8.39e-05	0.000281	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.39e-05	0.00028	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	8.35e-05	0.000279	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	8.33e-05	0.000279	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	8.28e-05	0.000277	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CALM1—type 2 diabetes mellitus	8.26e-05	0.000276	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	8.17e-05	0.000273	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.04e-05	0.000269	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	8.03e-05	0.000268	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—type 2 diabetes mellitus	8.02e-05	0.000268	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.9e-05	0.000264	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—type 2 diabetes mellitus	7.86e-05	0.000263	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.84e-05	0.000262	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—type 2 diabetes mellitus	7.81e-05	0.000261	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.79e-05	0.00026	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCB—type 2 diabetes mellitus	7.76e-05	0.000259	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—type 2 diabetes mellitus	7.75e-05	0.000259	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—type 2 diabetes mellitus	7.72e-05	0.000258	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.7e-05	0.000257	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—type 2 diabetes mellitus	7.66e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—type 2 diabetes mellitus	7.6e-05	0.000254	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—type 2 diabetes mellitus	7.56e-05	0.000253	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—type 2 diabetes mellitus	7.41e-05	0.000248	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.36e-05	0.000246	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.36e-05	0.000246	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.34e-05	0.000245	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—type 2 diabetes mellitus	7.33e-05	0.000245	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.21e-05	0.000241	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—type 2 diabetes mellitus	7.18e-05	0.00024	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—type 2 diabetes mellitus	7.18e-05	0.00024	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—type 2 diabetes mellitus	7.15e-05	0.000239	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.1e-05	0.000237	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	7.07e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.02e-05	0.000235	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—type 2 diabetes mellitus	6.97e-05	0.000233	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—type 2 diabetes mellitus	6.96e-05	0.000233	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—type 2 diabetes mellitus	6.78e-05	0.000227	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.78e-05	0.000226	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.75e-05	0.000226	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.73e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.72e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.66e-05	0.000223	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.63e-05	0.000222	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.6e-05	0.000221	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.54e-05	0.000219	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—type 2 diabetes mellitus	6.49e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.44e-05	0.000215	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.41e-05	0.000214	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RELA—type 2 diabetes mellitus	6.33e-05	0.000211	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.32e-05	0.000211	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—type 2 diabetes mellitus	6.26e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—type 2 diabetes mellitus	6.14e-05	0.000205	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—type 2 diabetes mellitus	6.11e-05	0.000204	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	6.06e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.04e-05	0.000202	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.02e-05	0.000201	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.94e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.93e-05	0.000198	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.91e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.91e-05	0.000197	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.8e-05	0.000194	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.77e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.72e-05	0.000191	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.64e-05	0.000188	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	5.6e-05	0.000187	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—type 2 diabetes mellitus	5.53e-05	0.000185	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.53e-05	0.000185	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NFKB1—type 2 diabetes mellitus	5.47e-05	0.000183	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.43e-05	0.000182	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—type 2 diabetes mellitus	5.39e-05	0.00018	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.38e-05	0.00018	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.38e-05	0.00018	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NFKB1—type 2 diabetes mellitus	5.33e-05	0.000178	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.33e-05	0.000178	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.17e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—type 2 diabetes mellitus	5.1e-05	0.00017	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.1e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	5.07e-05	0.000169	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5e-05	0.000167	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—type 2 diabetes mellitus	4.97e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.97e-05	0.000166	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.89e-05	0.000163	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.84e-05	0.000162	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—type 2 diabetes mellitus	4.81e-05	0.000161	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—type 2 diabetes mellitus	4.69e-05	0.000157	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.66e-05	0.000156	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.61e-05	0.000154	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.57e-05	0.000153	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.56e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.54e-05	0.000152	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—type 2 diabetes mellitus	4.47e-05	0.000149	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.44e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.37e-05	0.000146	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—type 2 diabetes mellitus	4.36e-05	0.000146	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.32e-05	0.000144	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.27e-05	0.000143	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—type 2 diabetes mellitus	4.26e-05	0.000142	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.19e-05	0.00014	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—type 2 diabetes mellitus	4.15e-05	0.000139	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.04e-05	0.000135	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	3.98e-05	0.000133	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.96e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.88e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.56e-05	0.000119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.49e-05	0.000117	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.47e-05	0.000116	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—type 2 diabetes mellitus	3.44e-05	0.000115	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—type 2 diabetes mellitus	3.35e-05	0.000112	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—type 2 diabetes mellitus	3.17e-05	0.000106	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—type 2 diabetes mellitus	3.09e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	2.68e-05	8.96e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.47e-05	8.27e-05	CbGpPWpGaD
